Moderna, Inc.
MRNANasdaqCIK 1682852HealthcareFiscal year ends Dec 31
Reports and events: 161 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-3011:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-408289 |
| 2026-09-0120:37 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-378505 |
| 2026-07-3120:17 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001682852-26-000150 |
| 2026-07-3111:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001682852-26-000147 |
| 2026-07-0811:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001682852-26-000134 |
| 2026-05-1110:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001682852-26-000101 |
| 2026-05-0120:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001682852-26-000060 |
| 2026-05-0110:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001682852-26-000057 |
| 2026-03-1620:31 ET | DEF 14A | Proxy statementPeriod 2026-05-06 | 0001308179-26-000081 |
| 2026-03-0501:20 ET | 8-K | 1.01 Entry into a material agreement | 0001682852-26-000047 |
| 2026-02-2021:02 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001682852-26-000033 |
| 2026-02-1312:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001682852-26-000015 |
| 2026-02-1123:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001682852-26-000012 |
| 2026-01-1212:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001682852-26-000007 |
| 2026-01-0514:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001682852-26-000003 |
| 2025-11-2421:29 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-25-053816 |
| 2025-11-2012:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-053318 |
| 2025-11-1321:19 ET | 8-K | 5.07 Shareholder vote results | 0001628280-25-052055 |
| 2025-11-0621:05 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001682852-25-000075 |
| 2025-11-0612:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001682852-25-000073 |
| 2025-10-1512:45 ET | DEF 14A | Proxy statementPeriod 2025-11-12 | 0001682852-25-000062 |
| 2025-08-0120:03 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001682852-25-000044 |
| 2025-08-0111:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001682852-25-000041 |
| 2025-05-0520:03 ET | 8-K | 5.07 Shareholder vote results | 0001682852-25-000036 |
| 2025-05-0120:02 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001682852-25-000034 |
| 2025-05-0110:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001682852-25-000031 |
| 2025-03-1120:07 ET | DEF 14A | Proxy statementPeriod 2025-04-30 | 0001308179-25-000082 |
| 2025-02-2112:11 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001682852-25-000022 |
| 2025-02-1411:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001682852-25-000006 |
| 2025-01-1312:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001682852-25-000002 |
| 2024-11-0721:03 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001682852-24-000060 |
| 2024-11-0711:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001682852-24-000057 |
| 2024-10-0211:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001682852-24-000052 |
| 2024-09-1210:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001682852-24-000049 |
| 2024-08-0120:02 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001682852-24-000046 |
| 2024-08-0110:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001682852-24-000043 |
| 2024-07-2311:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001682852-24-000035 |
| 2024-05-0921:58 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001682852-24-000031 |
| 2024-05-0220:03 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001682852-24-000027 |
| 2024-05-0210:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001682852-24-000023 |
| 2024-03-2112:46 ET | DEF 14A | Proxy statementPeriod 2024-05-06 | 0001308179-24-000208 |
| 2024-02-2321:03 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001682852-24-000015 |
| 2024-02-2211:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001682852-24-000010 |
| 2024-01-0812:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001682852-24-000004 |
| 2023-12-1213:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001682852-23-000049 |
| 2023-11-0613:02 ET | 8-K | 7.01 Regulation FD disclosure | 0001682852-23-000044 |
| 2023-11-0320:02 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001682852-23-000042 |
| 2023-11-0210:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001682852-23-000038 |
| 2023-10-1612:59 ET | 8-K | 7.01 Regulation FD disclosure | 0001682852-23-000033 |
| 2023-09-1112:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001682852-23-000030 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.